Government · 1 deal
Every published round Biomedical Translation Fund took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Denteric | Series A | undated | $14m | Lead | denteric.com (undated), denteric.com (undated) |
Companies Biomedical Translation Fund has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Denteric | Developing vaccine candidate targeting P. gingivalis linked to Alzheimer's | Series A | 1 | 1 |
Fund closes reported for Biomedical Translation Fund, as distinct from the investments it has made.
Companies Biomedical Translation Fund has backed that another company then bought. An exit for the holding, not a deal Biomedical Translation Fund did.
Stories naming Biomedical Translation Fund. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A Telethon Kids spin-out backed by Brandon Capital has begun trials in the US and Australia of RSP-1502, an inhaled antibiotic booster for cystic fibrosis lung infections, after strong early results in WA patients.
A Telethon Kids offshoot, Respirion Pharmaceuticals, is trialling its antibiotic-booster therapy RSP-1502 in the US and Australia, with backing from Brandon Capital and an American cystic fibrosis foundation.
US regulators cleared first-in-human testing of BiVACOR's total artificial heart; the OneVentures page also links earlier coverage and the Biomedical Translation Fund's investment in the device.
Denteric, a biotech spun out of an oral health research program, has raised $14 million for a gum disease vaccine, in a round led by the Biomedical Translation Fund with CSL also taking part.
Also denteric.com